BasicLab Light Normalizing Emulsion With 3% Noni Stem Cell Complex

Light Normalizing Emulsion With 3% Noni Stem Cell Complex

Product details

Description

This lightweight emulsion is used all over the face during the skincare step after cleansing.

  • It spreads into a thin layer without feeling heavy and gently sinks into the skin.
  • It leaves the skin feeling moisturized and balanced without an oily residue.
  • Its light, non-sticky feel makes it comfortable to use even on areas prone to shine.
  • Ideal for daily use when you want to keep the skin feeling simply refined.

We strive to provide accurate product information. The information shown here was provided by the manufacturer, suppliers, and other sources and has not been verified by us. Please see our disclaimer.

How to use
1) After cleansing, smooth the skin with toner. 2) Dispense an appropriate amount and spread a thin layer over the entire face. 3) Gently pat with your fingertips to help it absorb. 4) Complete the routine with the next skincare step.
Brand / Product name
/ Light Normalizing Emulsion With 3% Noni Stem Cell Complex

What's in it?

Based on the full ingredient list: Expected benefits 8 items

Based on the full ingredient list: Potential concerns 7 items

Key features

  • Alcohol-free
  • EU allergen-free
  • Fragrance-free
  • Oil-free
  • Paraben-free
  • Silicone-free
  • Sulfate-free
  • Reef-safe
  • Fungal acne-safe
Light Normalizing Emulsion With 3% Noni Stem Cell Complex Find dupes

This information is based on the properties of individual ingredients in the full ingredient list and does not indicate the efficacy of the product itself or clinical results.

There are no survey responses for this product yet.

Ask the community

Viewduc users haven’t asked any questions about Light Normalizing Emulsion With 3% Noni Stem Cell Complex yet.

Ratings & reviews

0
0 reviews
  • 5 stars, 0 reviews, 0%
  • 4 stars, 0 reviews, 0%
  • 3 stars, 0 reviews, 0%
  • 2 stars, 0 reviews, 0%
  • 1 stars, 0 reviews, 0%
This product has no reviews yet.